Shanghai Fosun Pharmaceutical Group
Shanghai Fosun Pharmaceutical Group Co Ltd is a Chinese healthcare enterprise engaged in biopharmaceutical research, medical devices, and healthcare services. The company develops, manufactures, and commercializes innovative biopharmaceuticals, generic drugs, diagnostic reagents, and medical devices alongside operating private hospital networks. Main revenue drivers include pharmaceutical product sales, commercial distribution revenues, medical device equipment sales, and hospital patient service fees. Fosun Pharma serves hospital networks, medical practitioners, diagnostic laboratories, and prescription drug consumers across mainland China and global markets. The company holds a market-leading position in China's pharmaceutical and private healthcare services industry. Headquartered in Shanghai, China, the company is listed on the Shanghai Stock Exchange and Hong Kong Stock Exchange.
4 of the funds FundTelligence covers report a position in Shanghai Fosun Pharmaceutical Group.
- Legal name
- Shanghai Fosun Pharmaceutical Group Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 4
Funds holding Shanghai Fosun Pharmaceutical Group
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.09 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.0 % (full portfolio disclosed, October 2026)
- KLP AksjeFremvoksende Markeder Indeks — KLP · 0.0 % (full portfolio disclosed, June 2026)